Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
11.06.25
/
50%
€85.00
Target price
11.06.26
€98.17
Performance (%)
29.41%
Price
15.08.25
€110.00
Summary
This prediction is currently active. The prediction currently has a performance of 29.41%. This prediction currently runs until 11.06.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 17.647% | 17.647% |
| iShares Core DAX® | 0.648% | 1.259% |
| iShares Nasdaq 100 | -0.034% | 2.797% |
| iShares Nikkei 225® | 2.445% | 9.854% |
| iShares S&P 500 | 0.492% | 2.570% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $100.00 to $112.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat